DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,258 filers reported holding DANAHER CORPORATION in Q3 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,653,000 | +2.9% | 12,317 | -15.5% | 0.05% | -9.3% |
| Q2 2020 | $2,579,000 | +46.3% | 14,583 | +14.5% | 0.05% | +20.0% |
| Q1 2020 | $1,763,000 | -26.4% | 12,733 | -18.4% | 0.04% | -16.7% |
| Q4 2019 | $2,394,000 | +12.2% | 15,597 | +5.5% | 0.05% | 0.0% |
| Q3 2019 | $2,134,000 | -7.4% | 14,777 | -8.4% | 0.05% | -12.9% |
| Q2 2019 | $2,304,000 | +12.3% | 16,124 | +3.8% | 0.06% | +5.1% |
| Q1 2019 | $2,051,000 | +93.5% | 15,539 | +51.1% | 0.06% | +68.6% |
| Q4 2018 | $1,060,000 | -8.3% | 10,281 | -3.4% | 0.04% | +6.1% |
| Q3 2018 | $1,156,000 | -13.7% | 10,643 | -21.6% | 0.03% | -19.5% |
| Q2 2018 | $1,340,000 | -21.3% | 13,577 | -21.9% | 0.04% | -25.5% |
| Q1 2018 | $1,702,000 | -12.7% | 17,385 | -17.2% | 0.06% | -11.3% |
| Q4 2017 | $1,950,000 | +25.7% | 21,005 | +16.2% | 0.06% | +12.7% |
| Q3 2017 | $1,551,000 | -3.7% | 18,082 | -5.2% | 0.06% | -11.3% |
| Q2 2017 | $1,610,000 | +3.7% | 19,075 | +5.1% | 0.06% | -3.1% |
| Q1 2017 | $1,553,000 | +48.8% | 18,158 | +35.4% | 0.06% | +33.3% |
| Q4 2016 | $1,044,000 | +129.5% | 13,410 | +131.3% | 0.05% | +118.2% |
| Q3 2016 | $455,000 | +5587.5% | 5,798 | +5076.8% | 0.02% | +2100.0% |
| Q1 2014 | $8,000 | -20.0% | 112 | -11.8% | 0.00% | 0.0% |
| Q4 2013 | $10,000 | 0.0% | 127 | -13.0% | 0.00% | 0.0% |
| Q3 2013 | $10,000 | -74.4% | 146 | -76.2% | 0.00% | -75.0% |
| Q2 2013 | $39,000 | – | 613 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |